New From Kineticos

Press Release

February 18, 2022

Recipharm Acquires Arranta Bio

Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announced the acquisition of Arranta Bio.

Press Release

January 7, 2022

Amylyx Pharmaceuticals Announces Pricing of Upsized Initial Public Offering of Common Stock

Press Release

September 8, 2021

EnteroBiotix secures $21.5M series A to advance microbiome drug pipeline

Press Release

April 28, 2021

Kineticos Announces Frank Lis as President and CEO of Kineticos Ventures

Kineticos announced today that Frank Lis has joined as President and Chief Executive Officer of Kineticos Ventures, a new subsidiary…

Press Release

February 24, 2021

Kineticos Disruptor Fund and Eos Advisory Form Partnership To Invest In Disruptive Life Science Companies in Scotland

St Andrews-based Eos Advisory has entered into a strategic partnership with Kineticos to co-invest in early-stage Scottish life sciences companies.…

Press Release

June 16, 2020

Kineticos’ Founder and CEO, Shailesh Maingi Joins Arranta Bio Board as Independent Director

Congratulations to Kineticos’ Founder and CEO, Shailesh Maingi, on joining the Arranta Bio board. Arranta Bio is a human microbiome…

Press Release

February 6, 2020

Kineticos Announces New Life Sciences Disruptor Fund That Will Launch and Invest in Early Stage Biotechs

Kineticos announced today the Kineticos Disruptor Fund, a new life sciences investment fund. The fund will invest in disruptive modalities…